According to Mark Cuban, there is an important opportunity for those taking a specific medication to access it at a reduced cost, even for those with insurance. This could potentially affect pharmaceutical investments and market strategies for investors considering the impact on drug pricing and access channels.

According to Mark Cuban's tweet, his support for CostPlus Drugs could influence healthcare stock traders by highlighting the potential market disruption caused by lower drug pricing, which may impact pharmaceutical company valuations.